Singular Genomics Systems, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Singular Genomics Systems, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2021 to Q3 2024.
  • Singular Genomics Systems, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $42.6M, a 27.1% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $42.6M -$15.9M -27.1% Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $56.4M +$12.5M +28.5% Jun 30, 2024 10-Q 2024-08-13
Q1 2024 $57.1M +$12.2M +27.2% Mar 31, 2024 10-Q 2024-05-14
Q4 2023 $57.8M +$11.9M +25.9% Dec 31, 2023 10-Q 2024-11-12
Q3 2023 $58.5M +$11.6M +24.7% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $43.9M -$4.38M -9.08% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $44.9M +$39.1M +681% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $45.9M +$45.9M Dec 31, 2022 10-K 2024-03-18
Q3 2022 $46.9M Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $48.2M Jun 30, 2022 10-Q 2022-08-09
Q1 2022 $5.75M Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $0 Dec 31, 2021 10-K 2023-03-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.